Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab

• Váldodahkkit: Isabela Soubhia Corral (Dahkki), Thais Helena Proença de Freitas (Dahkki), Renata Telles Rudge de Aquino (Dahkki), Daniella Abbruzzini S. Koller (Dahkki), Maria Elisa Ruffolo Magliari (Dahkki), Helena Muller (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Sociedade Brasileira de Dermatologia, 2013-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Pemphigus vulgaris is an autoimmune bullous disease whose therapy is based on systemic corticosteroids, with or without immunosuppressants. Rituximab is a chimeric monoclonal antibody of the IgG class, directed at a specific CD20 B cell surface antigen, used in pemphigus vulgaris empirically since 2...